Childhood Pancreatitis by Ali E. Abdelbasit
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Childhood Pancreatitis  
Ali E. Abdelbasit 
Department of Paediatric Surgery, Soba University Hospital,  
University of Khartoum,  
Sudan   
1. Introduction  
Most of the available English literature on pancreatitis is adult based. The last few decades 
have witnessed increasing interest in childhood pancreatitis and attention to research into 
the subject. Many recent published works have focused on various aspects of pancreatitis. 
The incidence of childhood pancreatitis is a rare event though it appears to be increasing. 
Despite its rarity, pancreatitis in children deserves special attention because of the 
significant morbidity and mortality associated with it. The management of childhood 
pancreatitis has also witnessed remarkable development in the last few decades. The 
improvement in the imaging resolutions, biochemical tests, endoscopic procedures and the 
intensive care facilities have resulted in better outcome. 
This chapter aims at providing an up-to-date review of childhood pancreatitis. It includes 
the aspects of aetiological factors, pathophysiology, classification, typical and atypical 
clinical presentation with abdominal and extra-abdominal manifestations of the disease and 
its complications, applicability of severity scores, the diagnostic and prognostic 
investigations, various methods of medical and surgical treatment - with indications thereof 
- touching on the pros and cons of the different methods, and the overall prognosis. 
2. Aetiology   
2.1 Acute pancreatitis  
The causes of acute pancreatitis in children are diverse (Table 1) and unlike in the adults 
where the majority of the cases are due to alcoholism or gallstone disease, most of the cases 
in children are due to pancreaticobiliary tract anomalies, biliary tract stones, trauma, drugs 
and a plethora of systemic diseases. In a considerable proportion of up to 25% of the 
patients, no aetiological factor is identified and is therefore labeled as idiopathic (Haddock 
et al., 1994; Uretsky et al., 1999; Mehta & Gittes, 2005; Hebra et al, 2009; Werlin, 2003).  
2.1.1 Pancreaticobiliary anomalies 
Pancreaticobiliary malunion (PBMU) accounts for approximately 6-33% of cases of 
pancreatitis in children. PBMU is used synonymously with common pancreaticobiliary 
channel, anomalous pancreaticobiliary channel, pancreaticobiliary maljunction, anomalous 
pancreaticobiliary ductal union or long common pancreaticobiliary channel, with or without 
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a choledochal cyst or common bile duct (CBD) dilatation. PBMU is complicated by bile 
reflux into the pancreatic duct predisposing to pancreatitis. Common channel and 
pancreatic duct obstruction by protein plugs, biliary stones or sludge may result in 
pancreatitis or jaundice. Presence of a choledochal cyst may produce pancreatitis by direct 
mechanical pancreatic duct compression (Miyano, 2006).   
Pancreas divisum is a persistence of the developmental pancreatic ductal system due to 
failure of fusion of the dorsal (Wirsung) and the ventral (Santorini) ducts. As a result, the 
exocrine drainage of the pancreatic body and tail is impaired due to the narrow minor duct 
and its papilla. The resultant flow impediment may cause recurrent episodes of acute 
pancreatitis. The anomaly is encountered in approximately 4-11% of patients and, as such, is 
one of the most common congenital anomalies of the pancreas (Miyano, 200; Mehta & Gittes, 
2005). Annular pancreas was reported to cause recurrent acute pancreatitis in children 
(Hwang et al 2010, Ohno & Kanematsu, 2008).  
2.1.2 Biliary stone disease 
Choledocho- or cholcystolithiasis are uncommon in children; however, when they exist 
they cause pancreatitis secondary to transient pancreatic duct obstruction. Biliary stones 
may result from haemolytic disorders such as hereditary spherocytosis, B thalassemia and 
sickle cell disease. Occasionally, biliary stones may complicate obesity or cholestasis due 
to biliary dyskinesia or prolonged use of total parenteral nutrition (TPN) (Mehta & Gittes 
2005). 
2.1.3 Trauma 
Trauma is a major cause of pancreatitis in children. By virtue of the position of the pancreas 
against the lumbar spine, accidents or violent acts leading to blunt abdominal trauma in 
children and adolescents - typically as in bicycle handle bar injuries- may cause acute 
pancreatitis. The severity of the trauma influences the onset of symptoms, severity of clinical 
manifestations and course of the disease. In cases of ambiguity of the history, child abuse 
must be taken into consideration. Iatrogenic pancreatitis may be experienced following 
pancreatic injury that occur during the course of abdominal surgery or may complicate 
endoscopic retrograde cholangiopancreatography ERCP (Miyano, 2006; Mehta & Gittes, 
2005; Uretsky et al., 1999; Ibrahim et al., 2011).       
2.1.4 Systemic infections 
Infection with viruses including Mumps, Rubella, Coxsackie B and Rotavirus can be 
incriminated in the aetiology of pancreatitis. Also, generalised bacterial sepsis may cause 
pancreatitis (Mehta & Gittes, 2005). 
2.1.5 Systemic diseases and metabolic abnormalities 
Including hypercalcaemia, hyperlipidaemia, hypertriglyceridaemia, Reye syndrome and 
Kawasaki’s disease, may be associated with cases of acute pancreatitis. Cystic fibrosis with 
inspissation of pancreatic secretions within the pancreatic ducts may cause recurrent acute 







Use of a wide range of drugs, including corticosteroids, HIV therapeutic agents, 
immunosuppressants and cytotoxic drugs, has been associated with incidents of acute 
pancreatitis accounting for 8-25% of cases (Miyano, 2006).  
Pancreatitis may be induced by the administration of corticosteroids and valproic acid. 
Perhaps young children are more commonly affected when valproic acid is incriminated. 
Bai found that there was a higher frequency of valproic acid-associated pancreatitis in 
children younger than 11 years of age (Bai et al., 2011).  
Didanosine (Nucleoside analogue) and Zalcitabine used in the treatment of human 
immunodeficiency viral (HIV) infection were incriminated as causative agents of acute 
pancreatitis (Ridout & Lakhoo, 2011). Butler et al found that pancreatitis developed in 7% of 
95 children with HIV who received the reverse transcriptase inhibitor Dideoxyinosine (ddI) 
at 60 to 540mg/m2 per day for a mean of 56 weeks. They also noted that pancreatitis 
occurred only in patients who received the highest dose levels and resolved in all of the 
affected children upon withdrawal of the drug (Butler et al, 1993).  
Immunosuppressive drugs such as Azathioprine and Mercaptopurine were incriminated as 
causative factors in approximately 5% of cases. The causative effect of Immunosuppressants 
can be reversed by early use of high doses of the synthetic protease inhibitor gabexate 
mesylate (Miyano, 2006). 
The use of the cytotoxic drug L asparaginase in leukaemia regimens was associated with a 
marked increase in acute pancreatitis in childhood oncology clinics (Nydegger et al., 2006). 
Ifosfamide used in the treatment of paediatric solid tumours is known to have serious 
adverse effects, including acute pancreatitis as a rare complication of therapy (Garg et al., 
2010). Tetracycline, erythromycin, metronidazole and nitrofurantoin are among other drugs 
reported to induce acute pancreatitis (Kuhls, 2004). 
Alcohol abuse is an uncommon cause of acute pancreatitis in children, however, it was 
reported to be implicated in older children and adolescents (Camp et al., 1994; Uretsky et al., 
1999). 
2.1.7 Miscellaneous 
Acute pancreatitis can be caused by hypovolaemia. The disease was related to 
hypovolaemia in one third (33%) of 21 children following cardiopulmonary bypass or severe 
GI bleeding (Berney, 1996).  
Liver transplantation was recently reported as a possible cause for acute pancreatitis, with 
an incidence of 1.9% and a mortality rate of 43% (Miyano, 2006). 
Early antenatal destruction of pancreas, Shwachman Diamond syndrome, is an autosomal 
recessive disorder recently mapped to the centromeic region of chromosome 7. Children 
suffering from this condition have pancreatic insufficiency at birth, generally with very low 
serum trypsinogen levels, indicative of nearly total exocrine pancreatic atrophy by birth 








Congenital anomalies of the biliary system: Choledochal cyst 
                                                                           Pancreatico-Biliary Malunion (PBMU) 
                                                                           Pancreas divisum  
Biliary stone disease: Cholelithiasis  
                                      Choledocholithisis 
Trauma: Blunt 
                Iatrogenic: Surgery, ERCP 
Infections: Viral and others:Mumps 
                                                 Rubella 
                                                 Coxsakie B virus 
                                                 Rota virus 
                                                 Generalised bacterial sepsis 
Chronic inflammatory diseases 
Systemic diseases:Cystic fibrosis,  
                              Reye syndrome,  
                              Kawasaki’s disease,                   
                              Hyperlipidaemia,  
                              Hypercalcaemia  
                              Hypertriglyceridaemia 
Drugs: Corticosteroids 
            Valproic acid  
 
            Anti HIV drugs: 
                             Didanosine (Nucleoside analogue)  
                             Zalcitabine  
 
            Immunosuppressive drugs  
                             Azathioprine  
                             Mecaptopurine 
            Cytotoxic drugs: L-Asparaginase 
                                         Ifofamide  
                                         Tetracycline, Pentamidine, 
                                         Sulphonamides, Metronidazole, Nitrofurantoin, 
                                         Ceftriaxone, Furosemide, 
                                         Rifampin, Interferon alpha-2b, Erythromycin 
  
Miscellaneous: Hypovolaemia 
                           Liver transplantation  
                           Early antenatal destruction of pancreas,  
                           Shwachman Diamond syndrome 
                           Hereditary pancreatitis 
                           Hyperactive sphincter of Oddi  
                           Extracorporeal Shock Wave Lithotripsy (ESWL) 
 
Idiopathic 






2.2 Chronic pancreatitis  
In children, the most common causes of chronic and chronic relapsing pancreatitis are 
trauma, hereditary, systemic disease and malformations of the pancreaticobiliary ductal 
system such as pancreas divisum and annular pancreas, and choledocholithiasis.  
Chronic pancreatitis could either be calcifying (commoner) or obstructive (less common).  
2.2.1 Calcifying chronic pancreatitis 
The most common cause of calcifying pancreatitis is hereditary or familial pancreatitis. 
Comfort and Steinberg gave the first description of hereditary pancreatitis in 1952 (Comfort 
& Steinberg, 1952). Since then a number of cases of hereditary pancreatitis have been 
reported. The mode of inheritance strongly suggested was an autosomal dominant trait 
(Aamarapurkar, 2001). The gene mutations identified in early-onset idiopathic chronic 
pancreatitis (ICP) are the serine protease inhibitor, Kazal type 1 (SPINK1) gene mutations, 
and the cystic fibrosis transmembrane regulator (CFTR) gene mutations. Recently, Cationic 
trypsinogen protease serine 1 PRSS1 gene mutations were detected in "idiopathic 
pancreatitis" and SPINK1 gene mutations in idiopathic and tropical pancreatitis. It is also 
very likely that SPINK1 gene mutations are important in tropical calcific pancreatitis (TCP) 
(see below) (DiMagno M & E., 2003). As many as 10% of patients with "idiopathic 
pancreatitis" may have hereditary pancreatitis if finding a PRSS1 gene mutation without a 
family history is considered an acceptable diagnostic criterion (DiMagno M & E, 2003). 
The association of CFTR gene mutations and chronic pancreatitis is well known. Even in 
classic cystic fibrosis (CF) with pancreatic functional preservation, the prevalence of 
pancreatitis may be 17% or higher because such patients have recurrent, severe abdominal 
pain that may be due to unrecognized pancreatitis (DiMagno M & E., 2003). 
Gene sequencing of the 7q35 chromosome region revealed a strong association of the 
(p.R122 H) mutation of the PRSS1 gene encoding cationic trypsinogen with hereditary 
pancreatitis (Teich et al., 2006). Developments in genetics have shown that in the majority of 
patients, hereditary pancreatitis is usually associated with expression of one of two specific 
mutations in the cationic trypsinogen PRSS1 gene, specifically R122H or N29I. Further 
sequencing of the PRSS1 gene in the proband of families without these common mutations 
revealed R122C and N29T mutations in independent families that segregated with the 
disease in an autosomal dominant fashion. The R122C mutation eliminates the arginine 
autolysis site as with R122H mutations. The N29T mutation may also enhance 
intrapancreatic trypsin activity as has been demonstrated in vitro (Pfutzer et al., 2002). 
Further mutations of this gene were discovered in patients with hereditary or idiopathic 
chronic pancreatitis. In vitro the mutations increase autocatalytic conversion of trypsinogen 
to active trypsin and thus probably cause premature intrapancreatic trypsinogen activation 
in vivo. The clinical presentation is highly variable, but most affected mutation carriers have 
relatively mild disease (Teich et al, 2006).  
Tropical calcific pancreatitis is a type of pancreatitis seen exclusively in tropics. Though the 
exact aetiology of tropical chronic pancreatitis is obscure, malnutrition with protein 
deficiency, cassava toxicity, impaired immune response, viral infection and genetic 
susceptibility have been considered as various factors in the aetiopathogenesis 
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(Aamarapurkar, 2001). It is also very likely that SPINK1 gene mutations are important in 
tropical calcific pancreatitis (TCP), a disease associated with malnutrition and cassava 
consumption in Afro-Asian countries that is characterized by onset at an early age and 
variable familial clustering (DiMagno M & E., 2003).. 
2.2.2 Obstructive chronic pancreatitis 
Encompasses the other causes of chronic pancreatitis in children which include congenital 
anomalies of the pancreaticobiliary duct system such as pancreas divisum, 
pancreaticobiliary malunion and annular pancreas. Trauma is also a major cause leading to 
chronic pancreatitis, particularly when fibrosis complicates pancreatic duct disruption, 
resulting in pancreatic duct stricture and, consequently, obstructive chronic pancreatitis. 
Other aetilogical factors include biliary disease, systemic inflammatory and metabolic 
diseases (table 2). Hypertriglyceridaemia and hyper parathyroidism, though rare, were 
reported to cause chronic pancreatitis in children (Aamarapurkar, 2001).  
Idiopathic fibrosing pancreatitis is a rare condition that affects children and adolescents. It 
can be a cause of recurrent abdominal pain and obstructive jaundice (Harb & Naon, 2005).  
Biliary disease  
                      Congenital anomalies of the biliary system:  Pancreas divisum  
                                                                                                  PBMU  
                                                                                                  Choledochal cyst 
                                                                                              
                       Biliary stone disease:   Cholelithiasis  
                                                              Choledocholithisis 
 
Hereditary pancreatitis 
Systemic and metabolic diseases:       Hyperlipoproteinaemia 
                                                               Hyperparathyroidism   
                                                               Hypercalcaemia 
                                                               Hypertriglycaedaemia 
                                                               Cystic fibrosis 
                                                               Inborn errors of metabolism  
                                                               Systemic lupus erythematosus 
                                                               Haemophilia 
                                                               Shwachman Diamond Syndrome  
Infection 
 
Chronic inflammatory diseases 
                                                            Crohn’s disease 
                                                            Ulcerative colitis                                                             
                                                            Chronic fibrosing pancreatitis 
                                                            Juvenile tropical pancreatitis 
                                                            Tropical calcific pancreatitis  
                                                            Idiopathic chronic pancreatitis 
                                                            Idiopathic fibrosing pancreatitis   







The pancreas matures after birth and by 2 years of age it is functioning in the same way as 
an adult pancreas. Due to its excellent reserve, the immature pancreas does not seem to 
affect the healthy children significantly, however, it can have a major impact on very ill or 
malnourished children (Durie, 2011).  
3.1 Acute pancreatitis 
3.1.1 Acinar cell injury  
Acute pancreatitis originates from acinar cell injury due to factors such as trauma, drugs, 
metabolic disorders and infection which lead to premature intraductal activation of 
proenzymes, specifically trypsinogen to trypsin. The resultant autodigestion of the 
pancreatic tissue and accompanying aggressive immune response cause the pathological 
process of pancreatitis and subsequent complications (Uretsky et al.,1999; Nydegger et al., 
2006) 
3.1.2 Proenzyme activation 
Inappropriate, premature proenzyme activation in the pancreas, and consequently 
autodigestion of pancreatic tissue, may occur due to either ductal flow obstruction 
(structural) with extravasation of enzyme rich ductal fluid into the parenchyma of the 
pancreas, reflux of duodenal enterokinase into the pancreas or failure in feed-back control 
(hereditary).  
3.1.3 Inflammatory mediators 
Once activated, elastase, phospholipase A2 and superoxide free radicles in addition to 
release from the pancreas of other active mediators including cytokines such as tumour 
necrosis factor-alpha; and vasoactive substances such as histamines, prostaglandins, kinins 
and kallikreins, are thought to play an important role as mediators of tissue damage (Weber 
& Adler, 2003; Mehta & Gittes, 2005).  
Along with premature activation of digestive enzymes, disturbances of intracellular 
calcium, and activation of transcription factors such as NF-κB characterize the initial phase 
of acute pancreatitis. Depending on the severity of pancreatic injury, the impact may not be 
confined to the pancreas. Pancreatic enzymes can cause damage at distant sites either by 
vascular dissemination or by the release of proinflammatory mediators and the recruitment 
of immune cells which may expand the local disturbances to a systemic inflammatory 
response associated with diffuse tissue damage throughout the body and failure of distant 
organs such as lungs or kidneys, a form of multiple system organ failure (MSOF). Patients 
with severe acute pancreatitis are, therefore, likely to have a high incidence of refractory 
sepsis and death (Weber & Adler, 2003; Mehta & Gittes, 2005). 
3.1.4 Role of cytokines 
Cytokines themselves do not induce pancreatitis but rather mediate the progression of 
pancreatitis. Cellular immune responses are the major determinants of severity. The most 
important step for the development of severe pancreatitis appears to be the activation of the 
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T helper cell type 1 (Th1) response. Pancreatic production of proinflammatory cytokines 
such as TNF-alpha, interleukin IL-1B, IL-6 and IL-8 modulates local injury, systemic 
inflammatory response and distant organ failure. This modulation, coupled with pancreatic 
necrosis, determine the outcome from acute pancreatitis. The TNFa, IL1B, IL6 & IL8 released 
from granulocytes and macrophages also reach the liver through the portosystemic 
circulation and act on Kupffer cells that produce more cytokines and acute phase proteins. 
Other factors determining the severity of pancreatitis include free radicles, pancreatic 
glutathione, ischaemia, chemokines and neurokines. Because the onset of cytokines action 
follows immediately after the onset of pancreatitis and peaks after 36-48 hours, cytokine 
antagonists therapy represent a potential therapeutic target and therefore is of intense 
interest (Nydegger et al, 2006; Berney et al, 1999).   
3.2 Chronic pancreatitis 
Chronic pancreatitis is an inflammatory disorder that results in anatomical changes that 
include chronic inflammatory cell infiltration and gland fibrosis, with loss of exocrine 
function (malabsorption) and endocrine function (diabetes mellitus). In susceptible children, 
repeated episodes of acute inflammation may lead to chronic pancreatitis, the so called 
necrosis-fibrosis hypothesis of Comfort et al. and, accordingly, it is likely that there is 
significant overlap in the underlying pathophysiology of these conditions (Nydegger et al, 
2006).  
Whitcomb has proposed a sentinel acute pancreatitis event SAPE which acts as a priori step 
toward the development of chronic pancreatitis. The acute injury must be sufficiently severe 
to attract monocytes and to cause infiltration, differentiation and proliferation of pancreatic 
stellate cells. For fibrosis to occur there must be recurrent acinar injury resulting in 
chemocytokine release that then stimulates stellate cells (Whitcomb 1999, 2004).   
Genetics: Cationic trypsinogen gene Protease Serine 1 (PRSS1) gene accounts for 65% of 
trypsinogen and is one of the most abundant molecules produced by acinar cells. In 
chronic pancreatitis, it has been suggested that mutations of the cationic trypsinogen 
PRSS1 gene lead to an alteration in the trypsin recognition site that prevents deactivation 
of trypsin within the pancreas. Consequently, autodigestion occurs resulting in 
pancreatitis. The genetic mutations responsible for hereditary pancreatitis have been 
isolated to chromosome 7q35. The most common hereditary pancreatitis causing 
mutations in PRSS1 gene are R122H and N29I (Pfutzeret al., 2002; Teich et al, 2006; 
Nydegger et al., 2006). These two mutations in the cationic trypsinogen gene appeared to 
allow prematurely activated trypsinogen to cause acinar cell auto-digestion and acute 
pancreatitis. Chronic pancreatitis in these patients certainly arises from recurrent acute 
pancreatitis (Aamarapurkar, 2001). Several other mutations in the PRSS1 gene have been 
identified including mutations in codons 16, 22, 23 and 122. This discovery of genetic 
mutations associated with hereditary pancreatitis support the hypothesis that 
intrapancreatic activation of pancreatic zymogens is crucial to the pathogenesis of acute 
pancreatitis. The mutant trypsin in hereditary pancreatitis is resistant to lysis, remains 
active and causes auto-digestion of the pancreas and episodes of acute pancreatitis. 
Median age at onset of disease is 11 years in patients with the N29I mutation and 10 years 
in those with the R122H. Approximately half of patients with hereditary pancreatitis 






Trypsin can exert a negative feed-back, self inactivation to protect the pancreas from auto-
digestion. The serine protease inhibitor SPINK1 produces a similar pancreas sparing effect by 
inhibition of prematurely activated trypsinogen. This gene may have a role in tropical 
pancreatitis, an idiopathic form of pancreatitis seen in southern Asia and parts of Africa and 
probably related to malnutrition, together with cassava intake. SPINK1 mutations were also 
shown to be associated with a subtype of tropical pancreatitis, fibrocalculous pancreatic 
diabetes. SPINK1 mutations alone probably do not cause pancreatitis but act as disease 
modifier. The SPINK1 mutations are relatively common, being present in approximately 2% of 
the general population. However, the frequency of SPINK1 mutations in populations with 
idiopathic chronic pancreatitis is markedly increased, approximately 25%, an evidence that an 
association exists between the SPINK1 mutations and pancreatitis (Nydegger et al., 2006).  
Cystic fibrosis transmembrane regulator (CFTR): An association between idiopathic chronic 
pancreatitis and CFTR gene mutations was reported. Several mild CFTR mutations were 
found to be associated with idiopathic pancreatitis. Available data suggest that patients with 
two severe mutations have classical cystic fibrosis (CF), those with a single mutation are 
carriers and those who are compound heterozygotes with one severe and one mild mutation 
are at risk of developing pancreatitis (Ridout & Lakhoo, 2011; Nydegger, 2006).  
4. Classification  
Pancreatitis can be classified as: 
- Acute pancreatitis: Simple 
                                       Necrotizing 
                                       Haemorrhagic 
- Acute recurrent pancreatitis  
- Chronic pancreatitis: Calcific or Obstructive 
- Chronic relapsing pancreatitis 
5. Clinical presentation 
5.1 Acute pancreatitis 
Diagnosis is based on symptoms and signs accompanied by a three fold increase in either 
amylase or lipase. Presentation is variable in children and symptoms may range from mild 
abdominal pain to severe systemic involvement, metabolic disturbances and shock. 
Abdominal pain, anorexia, nausea and vomiting are the most frequent symptoms (Hebra 
et al., 2009; Mehta & Gittes, 2005). The pain can be of a sudden or insidious onset with slow 
and gradual progression with increasing intensity. Although the pain is usually epigastric in 
origin, right and left upper abdominal quadrants are infrequently involved. Central and 
lower abdominal pain may also be encountered (Uretsky et al, 1999). The typical radiation of 
pain to the back observed in adults is not a common feature in children. Food intake 
exacerbates pain and vomiting (Haddock et al, 1994) while drawing the knees up to the 
chest relieves the pain (Uretsky et al, 1999). Extracellular fluid losses can be enormous 
(Mehta & Gittes, 2005).  
On examination, the child may be ill, irritable, quiet or a combination of these. Movement 
aggravates the abdominal pain, therefore children typically tend to assume a still, supine 
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position, or they may lie on their side or doubled up with the hips and knees flexed (Hebra 
et al, 2009). Tachycardia, mild fever, hypotension, jaundice and abdominal signs such as 
diffuse tenderness, rebound tenderness, guarding, distension and decreased or absent bowel 
sounds may be elicited (Nydegger et al., 2006, Hebra et al., 2009, Ibrahim & Gabr, 2011). 
Parotid enlargement may be observed occasionally (Haddock et al, 1994). In severe cases of 
necrotizing or haemorrhagic pancreatitis, haemorrhage may dissect from around the 
pancreas along the abdominal wall tissue planes appearing as discoloration either in the 
flanks (Grey Turner’s sign) or at the umbilicus (Cullen’s sign). These echymoses may take 1-
2 days to develop (Mehta & Gittes, 2005). These signs of haemorrhagic pancreatitis are 
seldom present in children (Nydegger et al, 2006). Evidence of pleural effusion or dyspnoea, 
with or without acute respiratory distress syndrome, may be found on examination of the 
chest (Uretsky et al, 1999, Ali et al, 2010). Recurrent acute pancreatitis is seen in 10% of 
children after the initial acute episode. It is more likely in children with structural 
anomalies, idiopathic and familial causes (Nydegger et al, 2006).  
5.2 Chronic pancreatitis     
Unlike acute pancreatitis in which complete reversal of the inflammatory changes occurs 
upon resolution of the episodes, chronic pancreatitis is characterised by permanent 
structural changes in the pancreas associated with varying degrees of pancreatic 
dysfunction and, accordingly, increased risk of developing pancreatic insufficiency, 
adenocarcinoma, and pancreatic pseudocysts. Patients with this disease typically present 
with chronic or recurrent upper abdominal pain with significant morbidity. The pain is most 
commonly described as epigastric, deep or radiating towards the back and accompanied by 
nausea and vomiting. It is often relieved by sitting and leaning forward and may increase 
following meal. It may commence as intermittent attacks with periods of well-being and 
then become more continuous, others may have little or no pain. Common other associated 
clinical features include weight loss and diabetes mellitus. Paediatric data on prevalence and 
incidence of exocrine and endocrine failure are limited, however, steatorrhea and weight 
loss will not occur until pancreatic exocrine function has been reduced to around 2% of the 
normal output. Because insulin and glucagons secreting cells are destroyed in chronic 
pancreatitis, the diabetes in these patients can be particularly refractory to treat (Nydegger 
et al, 2006; Mehta & Gittes 2005).  
Tropical calcific pancreatitis is characeritized by recurrent episodes of abdominal pain, 
severe malnutrition, and ketosis resistant diabetes. Ten per cent of patients with tropical 
calcific pancreatitis develop pancreatic cancer. Almost one third of patients with tropical 
calcific pancreatitis get recurrent episodes of pain in childhood and may develop diabetes in 
childhood (Aamarapurkar, 2001).  
6. Investigations  
6.1 Acute pancreatitis   
Serum amylase levels are usually, but not invariably elevated. Normal levels do not exclude 
the diagnosis of acute pancreatitis. Also, the degree of serum amylase elevation does not 
correlate with severity of the disease. Goh found that serum amylase levels were elevated in 






(Median 512.5). One third of them had amylase levels lower than 4 times the upper limit of 
normal, ie. 440 U/L. (Goh et al., 2003). Amplified elevations of serum amylase are 
suggestive of development of a pseudocyst or other complications of pancreatitis. 
Amylase is excreted in the urine when the level of hyperamylasemia exceeds the tubular 
reabsorptive capacity. Therefore, moderately elevated levels of serum amylase may not be 
detectable in the urine. It is important to note that other conditions may cause 
hyperamylasemia or hyperamylasuria. These include salivary inflammation or trauma, 
intestinal disease including perforation, ischaemia, necrosis or inflammation, renal failure 
and macroamylasemia (Mehta & Gittes, 2005). To differentiate the likely underlying cause, a 
three fold, or more, elevation of serum amylase concentration is strongly in favour of the 
diagnosis of acute pancreatitis. The half life of amylase is approximately 10 hours and the 
value frequently becomes normal after 2-5 days. 
Initial serum amylase level does not correlate with the severity of pancreatic injury. 
Schmittenbecher noted a longer lasting elevation of serum amylase in patients with 
traumatic pancreatitis (Schmittenbecher et al., 1996). 
Elevated level of pleural effusion fluid-amylase in children with respiratory symptoms 
secondary to pancreatitis is a useful diagnostic test (Segura, 2004). Thoracic pancreatic 
pseudocyst as a complication of traumatic pancreatitis has been reported (Ali et al, 2010).  
Lipase: Unlike amylase, lipase is produced only in the pancreas and its measurement is 
particularly helpful for distinguishing pancreatic trauma from salivary trauma. In children 
with acute pancreatitis, the serum lipase level is usually elevated for many days. Therefore, 
lipase levels have been proposed as a more specific test of pancreatic tissue damage. An 
important caveat to note here is that the degree of lipase elevation has little correlation with 
the extent of the pancreatitis and that intestinal perforation does cause an elevation of lipase 
through reabsorption via the peritoneum. Urinary lipase levels may remain elevated for a 
few days longer than serum levels (Mehta & Gittes, 2005).  
Calcium and Glucose: Hypocalcaemia was reported in 10-15% of children with pancreatitis 
(Goh et al., 2003; Uretsky et al., 1999) while hypoglycaemia was noted in 25% of cases 
during the acute attack (Uretsky et al., 1999).  
The blood glucose level measurement is a key investigation when chronic pancreatitis is 
suspected. Persistently elevated blood glucose level indicates significant pancreatic 
endocrine-reserve impairment.  
Haematological: Elevated total white blood cell counts (with increased band counts) are 
usually present (Goh et al., 2003). An increased haematocrit secondary to 
haemoconcentration that occurs after volume depletion may be found.  
Genetics: The majority of pancreatic diseases are associated with genetic polymorphism. 
Early use of genetic testing is likely to play a critical role in early diagnosis and prognosis of 
pancreatic diseases (Whitcomb, 2004).  
The levels of cationic trypsinogen gene and SPINK1 mutations are said to be a more 
sensitive early marker of pancreatic inflammation (Uretsky et al., 1999).  
Gene testing for CFTR gene is helpful in the diagnosis of pancreatitis in cases thought to be 
related to cystic fibrosis. 
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Imaging: plain abdominal radiographs may reveal obscured psoas margins, a sentinel loop 
of a dilated duodenum and a gasless segment of mid transverse colon. The latter is caused 
by local spasm with proximal dilatation known as colon cut-off sign due to inflammation of 
the adjacent pancreas. Pancreatic calcifications suggest chronic pancreatitis. In cases of 
tropical calcific pancreatitis, dense calcification is seen in pancreatic parenchyma (Mehta & 
Gittes, 2005).  
Plain chest x rays should be performed in all patients with acute pancreatitis to look for 
evidence of pleural effusion and pulmonary oedema (Mehta & Gittes, 2005). One fifth of 
children show evidence of pleural effusion (Uretsky et al., 1999).  
Ultrasound Scan (US): is one of the most useful imaging tools in childhood pancreatitis 
(Haddock et al., 1994). Abdominal US may show pancreatic swelling or a decrease in 
pancreatic echogenicity due to oedema or peri-pancreatic fluid collection. These findings per 
se are not sufficient to coin the diagnosis of acute pancreatitis or estimate its severity. The 
main use of US is to demonstrate gallstones as a possible cause of pancreatitis and to follow 
up the treatment by serial observation of improvement in oedema or peripancreatic fluid 
collection (Mehta & Gittes, 2005).  
Abdomominal CT scan: provides images of the pancreas superior to those obtained by US 
scan in as far as determining the size of the pancreas, the degree of oedema and the presence 
of fluid collection is concerned. Due to the much better resolution, the size and anatomy of 
the pancreatic duct can often be delineated much more accurately with CT than with US. 
The presence of complications such as pancreatic abscess or pseudocyst may also be 
determined. Dynamic CT pancreatography, using an intravenous bolus of contrast with 
rapid scanning in fine cuts through the pancreas, has the advantage of differentiating 
perfused from non-perfused (necrotic) pancreas. It has the ability to provide a precise 
assessment of the percentage of and distribution of pancreatic perfusion. Furthermore, CT 
scan can be used for interventional procedures for diagnosis or drainage of fluid collections 
(Mehta & Gittes, 2005).  
 
Fig. 1. An abdominal CT scan of a 10 year old child with blunt abdominal trauma. Note the 






ERCP: although the literature suggest that the complication rates with ERCP are higher in 
children than in adults, ERCP is being used increasingly in children. ERCP can provide 
detailed information on the pancreatic duct. It is particularly helpful for its diagnostic and 
therapeutic roles in the management of children with acute obstructive biliary pancreatitis. 
ERCP and pancreatic duct stenting can also be beneficial in trauma patients in whom a 
ductal injury is suspected or a pancreatic pseudocyst has formed (Mehta & Gittes, 2005, Ali 
et al., 2010). In cases of pancreas divisum, however, cannulation of the minor papilla is 
possible in less than half of the cases because of its small size and the angle at which it meets 
the duodenum (Miyano, 2006).   
MRCP: the magnetic resonance cholangio-pancreatography is a useful, non invasive 
diagnostic tool for evaluating the biliary tree and the pancreatic duct. This technique 
precludes the risk of complications encountered with ERCP. The study is cheaper and 
employs no radiation or administration of contrast media which is routinely performed with 
ERCP. MRCP is not without disadvantages. As an essentially diagnostic study, it does not 
facilitate therapeutic intervention and it has a tendency to overestimate the stenosis of the 
main pancreatic duct in patients with pancreatitis. Despite the recognized disadvantages, 
MRCP is now the initial imaging study of choice in the evaluation of pancreatic ductal 
anatomy in children with unexplained or recurrent pancreatitis (Mehta & Gittes, 2005).  
6.2 Chronic pancreatitis   
In children with suspected chronic pancreatitis the following investigations are suggested:  
- Sweat test and gene testing for CFTR  
- Testing for cationic trypsinogen and SPINK1 mutations  
- Assessment for autoimmune causes  
- Biochemical investigations for diabetes mellitus, lipase, electrolytes and stools for 
evidence of malabsorption 
- Imaging to exclude structural (congenital or acquired) abnormalities. In children with 
chronic pancreatitis, changes on imaging studies are usually encountered  
- Pancreatic biopsy, considered to be a gold standard for diagnosis in adults, is rarely if 
ever required in children (Nydegger et al., 2006).  
7. Severity scores  
Many scoring systems were used to assess the severity of acute pancreatitis in adults, 
however, there is no widely adopted robust severity scoring system that is specifically 
targeting children (Nydegger et al., 2006). The applicability of adult scoring systems such as 
Ranson's and the Imrie prognostic criteria, the Glasgow and modified Glasgow scores and 
the Acute Physiology and Chronic Health Evaluation (APACHE) II score have not been 
validated in children. An alternative severity scoring system has been suggested by other 
researchers. This group has compared a scoring system designed specifically to paediatric 
patients with selected adult scoring systems (DeBanto et al., 2002). This system compares 
eight variables to predict severe outcome and mortality during an episode of acute 
pancreatitis. An episode of pancreatitis is considered to be severe if the patient died, had 
surgery on the pancreas, developed a pseudocyst or abscess or infected necrosis, or met 
criteria for multiple organ dysfunction. The admission criteria considered are: 
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- Age <7 yrs  
- Weight <23Kg 
- WBC (Admission) >18.5/cmm 
- LDH (Admission) >2000 IU/L 
- 48hr trough albumin <2.6mg/dl 
- 48hr trough calcium <8.3mg/dl 
- 48hr fluid sequestration >75ml/kg/48hrs 
- 48hr rise in blood urea nitrogen >5mg/dl 
Each factor is allocated a score of 1 point and higher total scores are associated with an 
increased chance of severe pancreatitis and mortality.  
Scores of 5-7 points showed 80% severe outcome and 10% mortality  
                2-4 points showed 38.5 severe outcome and 5.8% mortality   
                0-2 points showed 8.6% severe outcome and 1.4% mortality 
When the cutoff for predicting severe outcome was set at 3 criteria, this new system had a 
sensitivity of 70%, a –ve predictive value of 91%, a specificity of 79% and a +ve predictive 
value of 45%. The system probably performs better in identifying those patients who are at 
risk for severe pancreatitis than the existing systems used in adults (DeBanto et al., 2002). 
When compared with the Ranson’s and Glasgow systems used in adult patients with 
pancreatitis, this system showed a better sensitivity (70%) versus Ranson (30%) and 
Glasgow (35%) scores and a better negative predictive value (91% vs 85% and 85% 
respectively) (DeBanto et al., 2002). In trauma, the grade of pancreatic injury was an 
independent predictor of both pancreatic complications (Kao et al., 2003).  
Some researchers associated the severity of pancreatitis to the aeiology. Haddock found that 
severe pancreatitis was most commonly associated with systemic disease (22 of 51; 43.1%) 
and trauma (13 of 51; 25.4%), beside associated factors such as significantly higher body 
weight, higher frequency of dyspnoea and pleural effusion, and lower serum calcium and 
albumin levels (Haddock et al., 1994; Chang et al., 2011). 
Many classification systems were adopted for grading of disease severity based on various 
factors. Examples of these classification systems include: 
- Marseille classification which relies on grading of biopsy specimens. 
- Cambridge classification with more emphasis on imaging to provide grading and 
severity scoring, Computed tomography (CT) was more accurate than ultrasound in 
evaluation of the severity of pancreatitis. 
- TIGAR-O system: more recently, the Toxic, Idiopathic, Genetic, Autoimmune, 
Recurrent severe associated chronic pancreatitis and Other systems has been developed 
and allows multiple risk factors to be assessed in an individual patient either as a risk 
factor or as an aetiology (Nydegger et al., 2006). 
- Atlanta criteria: though this is still controversial with lack of consensus (Berney et al., 
1999; Bollen et al., 2007). 
Overall, it is relevant to state that up till now commonly used scoring systems have limited 






Careful and repeated evaluations are essential in managing these patients as they may 
develop major complications without early signs (Lautz et al., 2011). 
8. Treatment  
8.1 Acute pancreatitis 
8.1.1 Conservative treatment  
Treatment of acute pancreatitis is primarily and essentially supportive. It aims at limiting 
exocrine pancreatic secretion and monitoring for acute and long term complications. Key 
features in the empirical therapeutic regimen commonly used in treating patients with acute 
pancreatitis are: aggressive IV fluid administration to replace the profound fluid deficit and 
to maintain a good hydration as indicated by adequate urine output (2ml/kg/hr), usually 
measured with the aid of an indwelling urinary catheter. Pain control should be achieved 
with parenteral analgesia. Adequate analgesia is critical to minimize the additional stress 
from pain. Meperidine (Demerol) is thought to be a better analgesic in pancreatitis because 
morphine is well known to cause spasm of the sphincter of Oddi which in turn is known to 
increase pancreatic duct pressure and potentially worsen the pancreatitis (Mehta & Gittes, 
2005). It is also important to be certain of the diagnosis of pancreatitis before giving the 
patient significant doses of narcotics because the ability to diagnose serious non-pancreatic 
problems, such as intestinal ischaemia or perforated ulcer, may be lost. It is imperative to 
have a very low threshold for transferring the patient to an intensive care unit and provide 
constant monitoring to avoid development of profound hypovolemia. Initially, bowel 
should be kept at rest with NG suction. Most mild to moderate cases will settle if food and 
drink is withheld for a few days. Proton pump inhibitors (PPI) or H2 receptor antagonists 
administration helps to prevent exposure of the duodenal secretin producing cells to gastric 
acid, which is a potent stimulator of pancreatic secretion. These antagonists also may help 
prevent stress ulceration seen in patients with pancreatitis. While clinical trials have shown 
improved outcome in acute pancreatitis by using long acting somatostatin analogues 
octreotides, controversy still exists concerning the use of prophylactic antibiotics. In 
general, mild to moderate cases probably do not benefit from antibiotics. More severe cases 
of pancreatitis, however, may benefit because of the high rate of sepsis. Prophylactic 
antibiotics are indicated when there is pancreatic necrosis or when infection is either 
suspected or documented in severe acute pancreatitis. Studies have related prophylactic 
antibiotic administration for 10-14 days in adult patients with severe acute pancreatitis and 
proven pancreatic tissue necrosis with decrease in superinfection of necrotic tissue and 
mortality (Nydegger et al., 2006; Mehta & Gittes, 2005; Miyano, 2006)). Some advantages 
have been demonstrated with the use of imipenem with reduction in the incidence of 
pancreatic sepsis in patients with necrotizing pancreatitis. Because the onset of cytokine 
action follows immediately after the onset of pancreatitis and peaks after 36-48 hours, 
cytokine antagonist therapy represents a potential therapeutic target and therefore is of 
intense interest (Nydegger et al., 2006). In children with relapsing attacks of pancreatitis we 
would advocate similar management and also include investigations to exclude structural, 
metabolic and hereditary pancreatitis (Nydegger et al., 2006). Nutrition is a crucial factor in 
the management of patients with pancreatitis. Early positive nitrogen balance has been 
shown to improve survival rates. This need for aggressive nutrition should come in the form 
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of early TPN administration. The TPN should include lipid formulations. To minimise the 
causal association of hyperlipidaemia and pancreatitis, it is recommended that serum lipid 
levels should be monitored to maintain triglyceride levels no greater than 500 mg/dl (Mehta 
& Gittes, 2005).  
The results of several controlled studies in adult patients with acute pancreatitis, support 
enteral nutrition. It costs less than TPN by approximately 1/4. Total enteral nutrition 
moderates the acute phase response and improves disease severity and clinical outcome 
despite unchanged pancreatic imaging findings (Windsor et al., 1998; Nydegger et al., 2006). 
Although there are sparse paediatric data, enteral feeding has been widely adopted. Perhaps 
a nasojejunal feeding with high protein and low-fat formula through a tube inserted under 
radiological or endoscopic guidance can be implemented until the child is ready to 
commence oral intake (Nydegger et al., 2006). Naso-jejunal feeding may be particularly 
useful in places where TPN availability is considered to be a luxury!.  
It is imperative to note that despite the known advantage of nutritional support in 
facilitating resolution of pancreatitis, quite often early commencement of enteral feeding 
results in relapse of acute abdominal pain and elevation of amylase levels. 
In general, the resumption of enteral nutrition should be cautious, usually after complete 
resolution of abdominal pain and preferably after normalization of the serum enzyme levels 
(Mehta & Gittes 2005).  
8.1.2 Surgical treatment  
Surgery for pancreatic disorders in children is rarely required. Surgical intervention in 
children with acute pancreatitis is even less practiced. It should be restricted to patients with 
complications such as severe necrotizing pancreatitis requiring debridement or patients 
with other complications associated with acute pancreatitis including pancreatic ascites, 
pancreatic abscess collections not amenable for percutaneous drainage and pancreatic 
pseudocyst (Rabinovich et al., 2006) (see below). 
In traumatic pancreatitis, as most children with a solid-organ abdominal injury can be 
managed conservatively, the pancreas is no exception. Non-operative management of low 
grade pancreatic injury is widely accepted. Management of major pancreatic parenchymal 
or ductal injury in children, however, remains controversial (Haddock et al., 1994; Stringer 
et al., 2005). Initial nonoperative management of injuries of the proximal pancreatic duct is a 
common practice and allows for the formation and uneventful delayed drainage of a 
pseudocyst, rather than the risks of early radical interventions (Jobst et al., 1999). If there is 
delayed or no response to conservative management, ERCP with sphincterotomy and/or 
stenting of injured pancreatic duct may be attempted as it has reportedly had a proven 
efficacy in resolving the symptoms in such patients (Cay et al., 2005; Canty & Weinman, 
2001; Ali, 2010). Distal duct injuries are best managed by prompt spleen-sparing distal 
pancreatectomy (Jobst et al., 1999). Removal of impacted stones in gallstone pancreatitis in 
children should be performed endoscopically (Mehta & Gittes, 2005).  
When discovered incidentally during the course of laparotomy for other suspected causes of 
peritonitis, it is imperative to palpate the gallbladder (GB) for stones. In the presence of 






pancreatitis, cholecystostomy may be the safer option which can provide an access to the 
biliary calculi later. Cholecystectomy can be done at a later stage when the patient’s 
condition is favourable. If no gallstones are present, but the patient has severe necrotizing 
pancreatitis, limited debridement and/or leaving large sump drains in place is probably 
adequate (Mehta & Gittes, 2005).  
Overall, early pancreatic lavage, pancreatic drainage, and pancreatic resection have not been 
shown to improve survival rates in cases of severe pancreatitis (Mehta & Gittes, 2005) and 
early intervention for pancreatic injury, in the absence of clinical deterioration or major 
ductal injury, is not recommended either (Keller et al., 1997). There is also an iatrogenic 
dimension to the problem as the rarity of pancreatic surgery in children caused an 
unfamiliarity that can be associated with contracting significant morbidity and mortality.  
When comparing traumatic and non-traumatic pancreatitis, Schmittenbecher and co-
researchers found that more patients with traumatic pancreatitis were operated on in 86% of 
cases and the rate of pseudocysts reached 61.5% whereas non-traumatic pancreatitis 
required surgical intervention in 50% and developed pseudocysts in 17% of cases. In non-
traumatic pancreatitis it is recommended that surgery should be avoided and reserved for 
complications. Exceptions are obstructions of the pancreaticobiliary ducts which need early 
removal to prevent chronicity of the disease and functional loss of the organ 
(Schmittenbecher, 1996). In their study, Stringer et al summarized the indications for 
surgery in acute pancreatitis in persistent pseudocysts and treatment of an underlying cause 
of pancreatitis (Stringer et al., 2005).  










Endoscopic intervention  
Surgical intervention 
8.2 Chronic pancreatitis      
Management of chronic pancreatitis is directed towards identification of the aetiological 
factors, diagnosis of the condition and hence implementation of the appropriate therapy. 
Due to the structural changes associated with chronic pancreatitis, many more surgical 
indications exist here when compared with acute pancreatitis. As appropriate, conservative 
management consists of provision of medications, analgesia, antibiotics and nutrition. 
Emphasis should be made on treatment of pancreatic exocrine insufficiency, therefore, 
digestive problems related to failure of the pancreas require enzyme replacement therapy 
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with meals as well as fat soluble vitamins supplements (Durie, 2010). Endocrine 
insufficiency, particularly diabetes mellitus, should be controlled.  
Indications for operative intervention include unsuccessful conservative medical therapy, 
intractable pain, narcotic addiction, impaired nutrition and poor weight gain. 
The goal of surgery in these patients is to relieve pain by provision of adequate analgesia 
and to preserve the exocrine and endocrine functions of the pancreas through 
decompression of pancreatic ducts and restoration of adequate pancreatic drainage.  
Surgical options include lateral longitudinal pancreaticojejunostomy (Puestow procedure), 
distal pancreatectomy with Roux-en-Y pancreaticojejunostomy (Duval procedure), ERCP 
sphincterotomy or operative sphincteroplasty. In cases of intractable and refractory disease, 
a few pediatric patients with chronic pancreatitis and chronic abdominal pain were 
successfully treated with total pancreatectomy and islet cell transplantation (Hebra et al., 
2009; Bellin et al., 2008).   
Surgical intervention is indicated for the management of congenital anatomic defects, such 
as pancreas divisum. The primary goal of treatment of pancreas divisum associated with 
pancreatitis is to establish adequate drainage of the duct of Santorini. This can be achieved 
with accessory papilla sphincteroplasty. Correct use of this procedure demands that 
intrapancreatic ductal obstruction be ruled out by pancreatography. The progression of 
disease to pancreatic insufficiency can be arrested when the obstruction is relieved early. 
Endoscopic stenting with or without sphincterotomy has been described, however, the 
technique requires particular skill with the endoscope in cannulation of the small ducts 
encountered in children. Re-stenosis and recurrence of symptoms have been reported 
following endoscopic sphincterotomy. 
If chronic pancreatitis has developed in the presence of a dilated duct, longitudinal 
pancreaticojejunostomy (Puestow) should be performed. The indication for the use of a 
direct ductal decompression procedure is evidence of pancreatic ductal ectasia with 
multiple intrapancreatic duct strictures, particularly when symptomatic (Stringer et al., 
2005). An important precautionary measure in any drainage procedure is preservation of 
existing endocrine function by avoiding major pancreatic resection. Longitudinal 
pancreaticojejunostomy (Puestow technique) in adults has been successful in eliminating or 
reducing pain intensity from chronic pancreatitis in 70 to 97% of patients. In children, some 
authors maintain that the Puestow procedure improves pancreatic function, decreases 
hospitalization and increases body weight toward ideal. Others have reported that distal 
pancreatectomy and pancreatico-jejunostomy are effective whereas longitudinal 
pancreaticojejunostomy is ineffective (Miyano, 2006). Traditionally, these procedures were 
performed with open surgery. A minimally invasive approach to the longitudinal 
pancreaticojejunostomy using robotic surgery in a child has been reported recently (Meehan 
& Sawin, 2011). Due to this controversy regarding appropriate operative procedures in 
paediatric cases, further consideration is warranted.  
Subtotal or total pancreatectomy is associated with considerable morbidity and mortality 
and is reserved for patients with intractable pain who have diffuse parenchymal damage 






DuBay et al. reported that in the treatment of complicated hereditary pancreatitis (HP) in 
children, the modified Puestow procedure (longitudinal pancreaticojejunostomy) improves 
the quality of life by improving pancreatic function, decreasing hospitalizations, and 
increasing the percentile ideal body weight. Direct pancreatic duct localization during the 
procedure reduces morbidity rate than localization via distal pancreatectomy. Surgery 
performed in the early stage of complicated disease may preserve pancreatic function 
(DuBay et al., 2000). Likewise, surgery for chronic relapsing pancreatitis is done to relieve 
pain, treat complications or both. Adequate surgical decompression, ultimately, can prevent 
disease recurrence (Clifton et al., 2007; Bellin et al., 2008).  
In children suffering from chronic pancreatitis complicated by diabetes mellitus, 
pancreatectomy and islet autotransplantation can prevent or reduce the severity of diabetes 
in about 75% of patients. Furthermore, outcome is noted to be better in younger than older 
children (Bellin et al., 2008).    
Treatment of chronic calcific pancreatitis includes control of diabetes, relief of pain with 
analgesics, pancreatic enzyme replacements, endoscopic or surgical decompression of 
dilated ducts and removal of pancreatic calculi (Aamarapurkar, 2001). 
The role of laparoscopy: laparoscopy has been reported to be used for common bile duct 
(CBD) exploration in obstructive recurrent pancreatitis (Shah et al., 1997). The commoner 
use of laparoscopy is for cholecystectomy when gallstones are incriminated in childhood 
pancreatitis. Laparoscopy has also been used in the treatment of pancreatic pseudocysts (see 
below). 
Surgery of the pancreas is generally of 3 types,  
1. Sphincteroplasty  
2. Pancreatic drainage via longitudinal pancreaticojejunostomy (Puestow)  
                                       or end to end pancreaticojejunostomy (Duval)  
                                       or pancreatogastrostomy (Smith)  
3. Pancreatectomy: partial or total  
9. Complications  
Expected local complications of childhood pancreatitis include necrotizing pancreatitis, 
haemorrhagic pancreatitis, pseudocyst and pancreatic fistula. While systemically, as cases of 
severe pancreatitis progress, close monitoring of the patients should be exercised for signs of 
development of hypovolaemic shock and of multiorgan system failure. Pleural effusion and 
pulmonary oedema can progress to severe adult respiratory distress syndrome with 
hypoxia requiring endotracheal intubation. The tense abdominal distention associated with 
pancreatitis, either due to ileus or ascites, frequently contributes to the hypoventilation. 
Hypocalcemia, hypomagnesemia, anaemia from haemorrhage, hyperglycemia, renal failure 
and late sepsis can be seen in these patients and require close monitoring and treatment.  
9.1 Acute haemorrhagic pancreatitis  
Most of the complications related to acute pancreatitis tend to occur in the first two weeks of 
onset of pain; and secondary infection and necrosis account for 70-80% of deaths (Munoz & 
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Katerndahl, 2000). Zhu et al. noted that pancreatic damage or pancreatic necrosis in critically 
ill children is characterized by acute onset, profound severity, short course and multiple 
organ failure. It may be asymptomatic in early stage, and can be easily missed (Zhu et al., 
2011).  
Acute hemorrhagic pancreatitis is a rare event in children. This serious complication of 
acute pancreatitis may be attended with a mortality rate approaching 50% because of shock, 
systemic inflammatory response syndrome with multiple organ dysfunction, acute 
respiratory distress syndrome (ARDS), disseminated intravascular coagulation (DIC), 
massive gastrointestinal bleeding and systemic sepsis or peritonitis. Clinical manifestations 
related to hemorrhagic pancreatitis may include Grey Turner sign (bluish discoloration of 
the flanks) or Cullen sign (discoloration of the periumbilical region) because of blood 
extravasation in the fascial planes of the abdominal wall. Additional signs include pleural 
effusions, haematemesis, melaena, and coma (Mehta & Gittes, 2005; Miyano 2006)  
9.2 Pancreatic pseudocysts     
9.2.1 Definition  
Pancreatic pseudocysts are localized collections of pancreatic secretions with no epithelial 
lining. They develop as a complication of pancreatitis where they were reported to 
complicate 10-23% of the acute episodes. When associated with abdominal trauma, the 
frequency rate of pseudocyst identification is higher than 50% (Hebra et al., 2009). The other 
common causes of pseudocysts in children are pancreatic duct obstruction, infection and, 
rarely, drug induced acute pancreatitis such as with valproic acid (Miyano, 2006; Mehta & 
Gittes, 2005).  
9.2.2 Pathology  
As a result of extravasation of digestive pancreatic enzymes, pseudocysts develop in the 
lesser sac between the pancreas posteriorly and the stomach anteriorly. The cavity is lined 
by fibroelastic connective tissue capsule due to inflammatory reaction on the surrounding 
organs such as the pancreas, stomach, duodenum, colon, small bowel and omentum. An 
acute pseudocyst develops a thick fibrous wall in 4 to 6 weeks (Mehta & Gittes, 2005). After 
6 weeks, a pancreatic pseudocyst is considered mature. Cysts may vary in size and if greater 
than 6 cm in size, resolution with conservative medical management is doubtful (Yoder et 
al., 2009). Cyst fluid is clear or straw coloured in most cases and may contain toothpaste-like 
debris. The amylase level of the cyst fluid is typically higher than 50000 U/mL (Miyano, 
2006).  
9.2.3 Diagnosis  
A pancreatic pseudocyst formation should be suspected in patients with a history of 
abdominal trauma or pancreatitis followed by clinical or radiological appearance of an 
upper abdominal mass. Common associated symptoms and signs include persistent 
abdominal pain, tenderness, abdominal mass, gastric outlet obstruction, anorexia, nausea 
and vomiting. Occasionally, gastrointestinal haemorrhage, weight loss, jaundice, chest pain, 






Pseudocysts may be acute or chronic. The acute pseudocyst has an irregular wall on CT 
scan, is tender and usually follows a recent episode of acute pancreatitis or trauma. Chronic 
pseudocysts are usually spherical with a thick wall and they are commonly seen in patients 
with chronic pancreatitis. It is important to distinguish these two types of pseudocysts 
because 50% of acute pseudocysts resolve without therapy, whereas chronic pseudocysts 
rarely do (Mehta & Gittes, 2005).  
US, CT and MRI are reliable imaging modalities in the diagnosis of pancreatic pseudocysts 
(Fig 2, a & b). These studies are highly sensitive for evaluating the thickness of the cyst wall 
and for observing changes in the cyst during the ensuing period of treatment. ERCP is often 
useful as a diagnostic and a therapeutic tool because it can definitively determine the status 
of the pancreatic duct and thus guide surgical intervention (Miyano, 2006).       
     
       a)        b) 
Fig. 2. Pseudocyst of the pancreas on a thoracoabdominal CT scan of an 18 month old child. 
Note the related posterior mediastinal cyst seen on picture film a. (a, transverse section; b, 
coronal section) 
9.2.4 Treatment  
Optimal management of pancreatic pseudocysts in children remains controversial. A large 
proportion of these pseudocysts tend to resolve with medical therapy alone and have a low 
risk for recurrence. Pseudocysts less than 5 cm in diameter usually disappear without 
intervention (Mehta & Gittes, 2005). Accordingly, drainage should be performed in patients 
with pseudocysts that are more than 6 weeks old and have a diameter more than 5 cm. 
Occasionally, a demonstrable cyst wall thickening sufficient for internal drainage may 
appear on CT as early as 3-4 weeks from the onset of symptoms (Miyano, 2006). 
Approximately 60% of pancreatic pseudocysts that are caused by blunt trauma require 
surgical intervention (Hebra et al., 2009).  
Available treatment options range from conservative medical management to surgical 
drainage. Conventional management involves supportive therapy over a 6-week interval 
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during which time the cyst may either resolve spontaneously or the cyst wall undergoes 
fibrous maturation, potentially allowing internal surgical drainage to the stomach or jejunum.  
Octreotide acetate, a long acting somatostatin analogue, has been shown to be successful in 
reducing exocrine function and, thereby, helps resolving pancreatic pseudocysts in children 
(Miyano, 2006; Mehta & Gittes, 2005).  
If the patient can not withstand major surgery, has an infected or an immature cyst, 
percutaneous external surgical drainage is preferred. U/S or CT guided percutaneous 
drainage is the treatment of choice for infected pseudocysts because these cysts typically 
have thin, weak walls not amenable to internal drainage. However, when compared with 
internal drainage, external drainage is generally associated with adverse consequences such 
as fistula formation and a higher recurrence rate (Miyano, 2006). 
Internal drainage, especially transgastric cysto-gastrostomy is widely used. There is 
significant evidence indicating that it is effective in the treatment of mature pancreatic 
pseudocysts (Miyano, 2006; Mehta & Gittes, 2005).  
Roux-en-Y cysto-jejunostomy is an alternative internal drainage procedure and is associated 
with less complications and recurrence rates. 
Though less commonly used than other operative procedures, contemplating cysto-
duodenostomy may be effective when a cyst is intimately adherent to the duodenum.  
Either pancreatico-duodenectomy or distal pancreatectomy, as indicated, is effective in 
treating patients with pseudocysts in selected cases. Pseudocysts in the body or tail of the 
pancreas or those involving the head and uncinate process of the pancreas that are not 
amenable to internal drainage are rare and may require distal or proximal pancreatic 
resection, respectively (Miyano, 2006).  
Minimally invasive drainage approaches to pancreatic pseudocysts were reported. Strategies 
for cysto-gastrostomy include transoesophago-gastric endoscopic cysto-gastrostomy and 
percutaneous drainage (Mehta & Gittes, 2005). The other minimally invasive technique is 
laparoscopic transgastric cysto-gastrostomy or laparoscopic cysto-jejunostomy. There are few 
reports on the use of laparoscopy in the management of pancreatic pseudocysts (Saad et al., 
2005; Sietz et al.,2006). In a multi-institutional retrospective review of 13 patients with a mean 
age of 10.4 years and mean weight of 52.1 kg who underwent laparoscopic cysto-gastrostomy 
with no conversions, the authors concluded that a laparoscopic approach to pancreatic cysto-
gastrostomy for chronic pseudocysts proved to be safe and effective. Techniques varied, but 
92% of patients had complete resolution with minimal morbidity and rapid recovery. 
Laparoscopic cysto-gastrostomy can be adopted as an appropriate first-line treatment for 
chronic pseudocysts in children (Yoder et al., 2009).  
Both endoscopic and laparoscopic drainage approaches are safe, efficient and effective, 
however, the two procedures should be performed at institutions with significant 
experience with these techniques to minimize serious potential risks.  
Treatment of persistent Pancreatic pseudocysts: 
- Internal drainage (preferred)  
- Excision (distal pseudocysts only)  






9.2.5 Pseudocyst complications    
Untreated pseudocysts may present with persistence of symptoms or become complicated 
with major haemorrhage, infection or cyst rupture. Haemorrhage can occur as a result of 
cyst pressure and erosion into an adjacent blood vessel and may be controlled with 
emergency angiography and embolization. For infected or ruptured pseudocysts, early 
intervention with external drainage is indicated (Miyano, 2006; Mehta & Gittes, 2005) 
9.3 Pancreatic ascites 
Pancreatic ascites is uncommon but may follow trauma or pancreatic surgery. Leakage of 
pancreatic fluid from a damaged major pancreatic duct results in ascites. Treatment is 
initially conservative and consists of bowel rest, TPN administration and use of long-acting 
somatostatin analogue. In many cases ascites resolves with this treatment. If not, ERCP or 
MRCP should be performed to determine the site of the ductal injury and, accordingly, the 
appropriate course of surgical intervention (Mehta & Gittes. 2005).  
9.4 Pleural effusion 
Occasionally, pancreatic pleural effusion may develop following severe pancreatitis. A 
significantly elevated level of pleural fluid amylase/lipase with concentrations higher than 
those obtained from patient’s serum sample, may be encountered following traumatic 
pancreatitis. Intrathoracic pancreatic pseudocyst has been reported following traumatic 
pancreatitis where, eventually, persistent pancreatic ductal leak was successfully managed 
with ERCP stenting of the pancreatic duct (Ali et al., 2010).   
9.5 Pancreatic abscess 
Infection may complicate necrotic pancreatic tissue or peripancreatic fluid collection 
resulting in pancreatic abscess. Abscess increases the mortality rate of pancreatitis threefold 
and is an absolute indication for surgical intervention. Persistence of fever and leukocytosis 
in a child with pancreatitis for more than 7 days is an indication for CT guided needle 
aspiration to differentiate pancreatic abscess from an uninfected pancreatic fluid collection. 
Dynamic CT pancreatography is a useful test in showing pancreatic necrosis which is a 
likely predisposing factor for the subsequent development of a pancreatic abscess. The 
definitive therapy for pancreatic abscess entails surgical debridement and adequate abscess 
cavity drainage (Mehta & Gittes, 2005).   
9.6 Pancreatic fistula 
Pancreatic fistula develops following surgical procedures in the pancreas. Most low output 
fistulas close spontaneously but may drain for several months. Long acting somatostatin 
analogue is beneficial in decreasing the fistula output and accelerating the rate of closure. 
Fistula closure can be facilitated by adequate nutrition, with TPN if enteral feeding results in 
high-volume output, and by ensuring that the fistula tract does not become obstructed. In 
persistent fistulas surgical Roux-en-Y jejunostomy to the leak point is recommended (Mehta 
& Gittes, 2005).  
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Both hyperglycaemia and diabetes can occur in children with pancreatitis. In a recent study, 
researchers looked at 176 patients who were up to 21 years of age and who were 
hospitalized with acute pancreatitis, acute recurrent pancreatitis, and chronic pancreatitis, 
excluding those with known pre-existing diabetes or cystic fibrosis before presentation with 
pancreatitis. Severe pancreatitis was associated with hyperglycaemia, and eight patients 
developed diabetes requiring insulin by the time of discharge. The authors noted that while 
adults tend to develop diabetes after chronic pancreatitis, children can develop diabetes due 
to a single episode of acute pancreatitis (Raman et al., 2011). 
9.8 Adenocarcinoma of the pancreas 
In patients with chronic pancreatitis, it has been reported that there is a 4% life risk of 
developing pancreatic adenocarcinoma. This risk may be as high as 40% in patients with 
hereditary pancraetitis (Nydegger et al., 2006).   
10. Prognosis  
Uncomplicated acute pancreatitis in children usually have excellent prognosis. The outcome 
also depends on the co-morbid conditions (Werlin 2003). The mortality rate is approximately 
10% in mild disease and up to 90% in cases of necrotizing or haemaorrhagic pancreatitis 
(Uretsky 1999). 
11. Conclusion  
Pancreatitis in children is an uncommon event, however, it is attended with significant 
morbidity and mortality. The presentation may range from transient mild symptoms to life 
threatening, overwhelming sepsis, multiple organ system failure and death. Prompt 
institution of appropriate diagnostic and therapeutic measures is crucial to achieve good 
clinical results. Conservative management and minimally invasive surgical and endoscopic 
procedures are usually sufficient to treat most of the patients. Children rarely need surgical 
intervention for the treatment of pancreatitis and its complications. Further developments 
are anticipated in the field of research, diagnostic tools, disease severity scoring and 
therapeutic methods to improve the outcome. 
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